TriSalus Life Sciences, Inc. — Cash Flow Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Cash Flow
Cash Flow by Activity
Operating Cash Flow↑+58.6% +$6M
$-4M
Free Cash Flow↑+18.0% +$9K
$-41K
Investing Cash Flow
$93K
Financing Cash Flow↓-90.7% -$3M
$277K
Capex↓-18.0% -$9K
$41K
Stock Buybacks
—
Stock-Based Comp↑+29.5% +$500K
$2M
D&A↓-34.7% -$67K
$126K
SBC Allocated Expense↑+29.5% +$500K
$2M